Subgroup analyses suggest an individualized approach may be helpful, but the findings are not definitive, one expert says.

(ARGX) stock is in focus as the FDA expands the label of its blockbuster therapy Vyvgart for a broader group of patients with ...

Full-year guidance was raised in Q1 2026, with CFO Bueker stating revenue is "up 40 basis points from our previous guide," while Q4 2025 positioned 2026 around the initial guide and a framework that ...

Accord Healthcare, Inc., a leading generic pharmaceutical company, committed to improving access to affordable medicines, today announced the relaunch of Tadalafil Tablets, an FDA-approved ...

A new beta build of Orion for Linux is available, with the v0.3 update described by its makers, the search company Kagi, as ...

The Minnesota Vikings had a busy offseason, moving on from one general manager and working to hire another. They’ve also […] ...

As we depart spring practice, it's time to take stock of the Longhorns roster today. We'll start with the offensive x-factors ...

This year's crop of top draft prospects have some impressive pro player comps, from Jared Goff to Davante Adams to Fred ...

Arch Manning and Jeremiah Smith are already household names, but these under-the-radar college football stars emerge as popular picks in the 2027 NFL Draft ...

Rookie draft season is underway. For those of us still looking ahead to our rookie draft(s), research is imperative. This ...

Beta-blockers have been a heart care staple for decades, but not all are created equal. New research is clarifying how nebivolol and carvedilol differ in their mechanisms, benefits, and side effects.